On June 11, 2019, MIT Center for Biomedical Innovation Executive Director Gigi Hirsch, MD, addressed the 4th Regulatory Innovation Evening held at Sanofi. This event brings pharmaceutical and regulatory professionals together … Read More
American College of Rheumatology joins NEWDIGS LEAPS Project
Initiative to design a systemwide “learning engine” for rheumatoid arthritis in Massachusetts The American College of Rheumatology (ACR), an international medical association that serves more than 8,500 members of the … Read More
Address: From Bigger Data to Smarter Evidence
On Tuesday, February 26th, Dr Gigi Hirsch, Executive Director of MIT NEWDIGS, gave a presentation for the Harvard-MIT Center for Regulatory Science to a gathering of local academic, clinical, and industry leaders … Read More
Preparing Patients and the Health System for Curative Therapies in the Pipeline
American Journal of Managed Care Curative therapies represent a conundrum for healthcare. On the one hand, there is the ability to cure patients of potentially life-threatening diseases or diseases that … Read More
MIT Releases New Policy and Practice Suggestions to Make Cures Accessible and Sustainable
Innovative Therapies Will Require Innovations in Financing and Regulations WASHINGTON, DC, February 12—Today, the MIT-based Financing and Reimbursement of Cures in the US (FoCUS) consortium released a series of large-scale … Read More
“Dynamic Dossier in the Cloud” to Transform Data Sharing, Starting with Federal Regulators
New platform will redefine biopharmaceutical data sharingMIT NEWDIGS and the Harvard-MIT Center for Regulatory Science announced the Dynamic Dossier in the Cloud today, a radical new platform that promises to … Read More
MIT LEAPS Design Lab Shapes Blueprint for Rheumatoid Arthritis Pilot in Massachusetts
CAMBRIDGE, MASSACHUSETTS — An international community of biomedical and healthcare innovation leaders gathered at MIT on December 12 and 13 for the second Design Lab for LEAPS (Learning Ecosystems Accelerator … Read More
NPR: “A Search For New Ways To Pay For Drugs That Cost A Mint”
Installment plans and refunds for treatments that don’t work are two options getting more attention as ultra-expensive therapies become more common. The financial strains will only grow. Read and hear … Read More
FasterCures joins NEWDIGS Initiative at MIT as a Strategic Partner
Collaboration to drive innovation across healthcare ecosystem CAMBRIDGE, MA, 21 SEPTEMBER 2018–FasterCures, a center of the Milken Institute devoted to saving lives by speeding up and improving the medical research … Read More